![Self-Referenced Synthetic Urinary Biomarker for Quantitative Monitoring of Cancer Development | Journal of the American Chemical Society Self-Referenced Synthetic Urinary Biomarker for Quantitative Monitoring of Cancer Development | Journal of the American Chemical Society](https://pubs.acs.org/cms/10.1021/jacs.2c09538/asset/images/medium/ja2c09538_0002.gif)
Self-Referenced Synthetic Urinary Biomarker for Quantitative Monitoring of Cancer Development | Journal of the American Chemical Society
![Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research | British Journal of Cancer Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41416-021-01610-8/MediaObjects/41416_2021_1610_Fig1_HTML.png)
Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research | British Journal of Cancer
![Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-021-02026-1/MediaObjects/13046_2021_2026_Fig5_HTML.png)
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
![Mapping the immune environment in clear cell renal carcinoma by single-cell genomics | Communications Biology Mapping the immune environment in clear cell renal carcinoma by single-cell genomics | Communications Biology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs42003-020-01625-6/MediaObjects/42003_2020_1625_Fig1_HTML.png)
Mapping the immune environment in clear cell renal carcinoma by single-cell genomics | Communications Biology
![Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach - eBioMedicine Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach - eBioMedicine](https://www.thelancet.com/cms/attachment/efeb09d3-4d87-4860-b235-6798c71171ce/gr1_lrg.jpg)
Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach - eBioMedicine
![Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-021-02026-1/MediaObjects/13046_2021_2026_Fig1_HTML.png)
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
![Frontiers | IFI16 Can Be Used as a Biomarker for Diagnosis of Renal Cell Carcinoma and Prediction of Patient Survival Frontiers | IFI16 Can Be Used as a Biomarker for Diagnosis of Renal Cell Carcinoma and Prediction of Patient Survival](https://www.frontiersin.org/files/MyHome%20Article%20Library/599952/599952_Thumb_400.jpg)
Frontiers | IFI16 Can Be Used as a Biomarker for Diagnosis of Renal Cell Carcinoma and Prediction of Patient Survival
![Cancers | Free Full-Text | From Immunohistochemistry to New Digital Ecosystems: A State-of-the-Art Biomarker Review for Precision Breast Cancer Medicine Cancers | Free Full-Text | From Immunohistochemistry to New Digital Ecosystems: A State-of-the-Art Biomarker Review for Precision Breast Cancer Medicine](https://www.mdpi.com/cancers/cancers-14-03469/article_deploy/html/images/cancers-14-03469-g001.png)